Sharmila Banerjee Selected Research

phosphonic acid

12/2014	Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
12/2013	Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids.
7/2009	(170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
4/2008	177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sharmila Banerjee Research Topics

Disease

41	Neoplasms (Cancer) 09/2023 - 02/2003
18	Pain (Aches) 10/2021 - 08/2002
17	Neoplasm Metastasis (Metastasis) 09/2023 - 08/2002
9	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022 - 06/2011
8	Breast Neoplasms (Breast Cancer) 02/2024 - 07/2005
8	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 10/2011
6	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 05/2015
6	Fibrosarcoma 01/2018 - 02/2010
5	Hypoxia (Hypoxemia) 01/2016 - 07/2005
4	Carcinoma (Carcinomatosis) 10/2021 - 11/2006
3	Lymphoma (Lymphomas) 09/2023 - 02/2010
3	Liver Neoplasms (Liver Cancer) 05/2009 - 07/2008
2	Nausea 02/2024 - 01/2021
2	Infertility (Sterility) 01/2020 - 11/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 01/2017
2	Osteosarcoma (Osteogenic Sarcoma) 06/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 03/2017 - 06/2007
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 10/2010
1	Ovarian Epithelial Carcinoma 06/2022
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Medullary Carcinoma 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 05/2019
1	Glioma (Gliomas) 05/2019
1	Bone Neoplasms (Bone Cancer) 10/2018
1	Anaplastic Thyroid Carcinoma 09/2018

Drug/Important Bio-Agent (IBA)

21	Radioisotopes (Radionuclides)IBA 04/2022 - 12/2004
17	RadiopharmaceuticalsIBA 10/2021 - 12/2004
10	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2024 - 08/2004
8	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 08/2004
7	Peptide Receptors (Peptide Receptor)IBA 04/2022 - 01/2016
6	AcidsIBA 06/2017 - 12/2004
6	PorphyrinsIBA 02/2015 - 02/2010
5	LigandsIBA 06/2022 - 05/2004
4	lutetium ethylenediaminetetramethylene phosphonic acidIBA 10/2021 - 03/2014
4	Durapatite (Hydroxylapatite)IBA 01/2016 - 07/2008
4	phosphonic acidIBA 12/2014 - 04/2008
3	Trastuzumab (Herceptin)FDA Link 04/2024 - 06/2022
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2022 - 08/2004
3	AntigensIBA 10/2021 - 01/2016
3	DOTA(0)-Tyr(3)-Thr(8)- 90Y-octreotateIBA 03/2021 - 09/2020
3	lutetium Lu 177 dotatateIBA 01/2021 - 01/2016
3	Thyroglobulin FDA Link 01/2021 - 05/2015
3	1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA 01/2018 - 12/2013
2	Rituximab (Mabthera)FDA Link 09/2023 - 01/2017
2	LutetiumIBA 04/2022 - 07/2011
2	177Lu-PSMA-617IBA 04/2021 - 12/2019
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2016
2	EndotoxinsIBA 01/2020 - 11/2014
2	Tumor Biomarkers (Tumor Markers)IBA 10/2019 - 01/2016
2	Peptides (Polypeptides)IBA 01/2018 - 03/2013
2	Organophosphonates (Phosphonates)IBA 01/2018 - 05/2004
2	IntegrinsIBA 03/2017 - 03/2013
2	AntibodiesIBA 01/2017 - 07/2005
2	177Lu- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid)IBA 12/2016 - 09/2008
2	MetalsIBA 01/2016 - 09/2008
2	MisonidazoleIBA 03/2015 - 03/2013
2	fluoromisonidazoleIBA 03/2015 - 08/2014
2	iminodiacetic acidIBA 08/2014 - 12/2006
2	Colchicine FDA LinkGeneric 08/2014 - 02/2006
2	NitroimidazolesIBA 08/2014 - 07/2005
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2014 - 02/2006
2	Androgen Receptors (Androgen Receptor)IBA 10/2011 - 11/2006
2	Estrogen ReceptorsIBA 07/2011 - 07/2005
2	Ethiodized Oil (Ethiodol)FDA Link 10/2010 - 05/2009
2	Metronidazole (Metric)FDA LinkGeneric 07/2005 - 02/2003
1	AntiemeticsIBA 02/2024
1	Humanized Monoclonal AntibodiesIBA 09/2023
1	Lutetium-177IBA 09/2023
1	AutoantibodiesIBA 10/2022
1	Iodide Peroxidase (Deiodinase)IBA 10/2022
1	anti-thyroglobulinIBA 10/2022
1	pertuzumabIBA 06/2022
1	human ERBB2 proteinIBA 06/2022
1	Hormones (Hormone)IBA 10/2021
1	gallium 68 PSMA-11IBA 04/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020
1	Fibroins (Fibroin)IBA 12/2020
1	AndrogensIBA 01/2020
1	Monoclonal AntibodiesIBA 12/2019
1	131I-rituximabIBA 12/2019
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2019
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 05/2019
1	Androgen Antagonists (Antiandrogens)IBA 12/2018
1	jugloneIBA 09/2018
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 09/2018
1	CatalaseIBA 09/2018
1	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2018
1	NGR peptideIBA 01/2018

Therapy/Procedure

30	Therapeutics 09/2023 - 08/2004
5	Palliative Care (Palliative Therapy) 01/2016 - 08/2002
4	Radioimmunotherapy 02/2024 - 01/2017
4	Precision Medicine 03/2017 - 01/2016
4	Radiotherapy 04/2011 - 09/2008
3	Drug Therapy (Chemotherapy) 01/2020 - 02/2006
2	Gamma Cameras (Gamma Camera) 02/2024 - 07/2010
2	Castration 04/2021 - 12/2018
1	Injections 01/2022
1	Orchiectomy (Orchidectomy) 10/2021
1	Secondary Prevention 01/2020